Innate Pharma
Clinical-stage biotech developing immunotherapies for cancer using the innate immune system.
IPH | PA
Overview
Corporate Details
- ISIN(s):
- FR0010331421 (+1 more)
- LEI:
- 9695002Y8420ZB8HJE29
- Country:
- France
- Address:
- 117 AVENUE DE LUMINY, 13009 MARSEILLE
- Website:
- http://www.innate-pharma.com/
- Sector:
- Manufacturing
Description
Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-06-14 07:00 |
Nouveau Nombre D’Actions et de Droits de Vote d’Innate Pharma au 1er Juin 2021
|
French | 114.4 KB | ||
| 2021-06-14 07:00 |
Number of Shares and Voting Rights of Innate Pharma as of June 1, 2021
|
English | 111.2 KB | ||
| 2021-06-10 07:00 |
Innate Pharma Presentera des Données Issues de sa Plateforme de NK Cell Engager…
|
French | 149.7 KB | ||
| 2021-06-10 07:00 |
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at …
|
English | 162.6 KB | ||
| 2021-06-09 12:00 |
New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at …
|
English | 147.7 KB | ||
| 2021-06-09 12:00 |
De Nouvelles Données pour Lacutamab Issues de l'Essai TELLOMAK Seront Partagées…
|
French | 140.3 KB | ||
| 2021-05-28 22:01 |
Résultats de l’Assemblée Générale d'Innate Pharma
|
French | 127.1 KB | ||
| 2021-05-28 22:01 |
Outcome of Innate Pharma’s Annual General Meeting
|
English | 109.2 KB | ||
| 2021-05-25 07:00 |
Nouveau Nombre D'Actions et de Droits de Vote d'Innate Pharma au 1er Mai 2021
|
French | 114.1 KB | ||
| 2021-05-25 07:00 |
Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021
|
English | 110.6 KB | ||
| 2021-05-12 07:00 |
Innate Pharma : Assemblée Générale 2021 a Distance
|
French | 114.9 KB | ||
| 2021-05-12 07:00 |
Innate Pharma Virtual 2021 Annual General Meeting
|
English | 119.3 KB | ||
| 2021-05-11 07:00 |
Information Financiere du Premier Trimestre 2021
|
French | 171.4 KB | ||
| 2021-05-11 07:00 |
Innate Pharma First Quarter 2021 Report
|
English | 181.3 KB | ||
| 2021-05-04 07:00 |
Innate Pharma Organise une Conférence Téléphonique et un Webcast pour son Infor…
|
French | 93.7 KB |
Automate Your Workflow. Get a real-time feed of all Innate Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Innate Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Innate Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Buy | 6,000 | N/A |
| 2024-01-02 | N/A | Other | Buy | 20,000 | N/A |
Peer Companies
